Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | More
 
or
Watchlist | Portfolio
Site News
Contact
Market:

Mountain Crest Acquisition Corp II (MCAD)

Mountain Crest Acquisition Corp II (MCAD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Help
Go To:
Better Therapeutics Closes Business Combination and Debuts on Nasdaq Business Wire - Fri Oct 29, 2021

Better Therapeutics, Inc., a prescription digital therapeutics (PDT) company delivering cognitive behavioral therapy to address the root causes of cardiometabolic diseases, today announced the completion...

MCAD : 10.43 (-4.92%)
Mountain Crest Acquisition Corp. II Stockholders Approve Business Combination with Better Therapeutics Inc. Globe Newswire - Wed Oct 27, 2021

Trading Under New Ticker Symbol “BTTX” Expected to Begin Friday, October 29, 2021...

MCAD : 10.43 (-4.92%)
Mountain Crest Acquisition Corp. II and Better Therapeutics, Inc. Announce Registration Statement Effectiveness and Scheduled Special Meeting to Approve Business Combination on October 27, 2021 Globe Newswire - Tue Oct 12, 2021

NEW YORK and SAN FRANCISCO, Oct. 12, 2021 (GLOBE NEWSWIRE) -- Mountain Crest Acquisition Corp. II (NASDAQ: MCAD, “Mountain Crest II”), a publicly-traded...

MCAD : 10.43 (-4.92%)
Better Therapeutics to Participate in Lake Street’s 5th Annual Best Ideas Growth (BIG5) Conference on September 14-15, 2021 Business Wire - Fri Sep 10, 2021

Better Therapeutics, Inc. (“Better Therapeutics”), a prescription digital therapeutics (PDT) company developing cognitive behavioral therapy to address root causes of cardiometabolic diseases, has...

MCAD : 10.43 (-4.92%)
Better Therapeutics Highlights Recent Progress and Updates Outlook Through 2022 Business Wire - Thu Sep 9, 2021

Better Therapeutics, Inc. (“Better Therapeutics”), a prescription digital therapeutics (PDT) company developing cognitive behavioral therapy to address root causes of cardiometabolic diseases, today...

MCAD : 10.43 (-4.92%)
Better Therapeutics Secures $50 Million Debt Facility From Hercules Capital Business Wire - Wed Aug 25, 2021

Better Therapeutics, Inc. (“Better Therapeutics”), a prescription digital therapeutics company developing cognitive behavioral therapy to address the root causes of cardiometabolic diseases, today...

HTGC : 19.43 (+0.67%)
MCAD : 10.43 (-4.92%)
Better Therapeutics Expands Real-World Evidence Study Initiative With Addition of Catalyst Health Network Business Wire - Tue Aug 24, 2021

Better Therapeutics, Inc. (“Better Therapeutics”), a prescription digital therapeutics company developing cognitive behavioral therapy to address the root causes of cardiometabolic diseases, in partnership...

MCAD : 10.43 (-4.92%)
Better Therapeutics to Participate in Cowen 6th Annual FutureHealth Conference Business Wire - Mon Jun 14, 2021

Better Therapeutics, Inc. (“Better Therapeutics”), a prescription digital therapeutics company delivering cognitive behavioral therapy to address the root causes of cardiometabolic diseases, today...

MCAD : 10.43 (-4.92%)
SHAREHOLDER ALERT: Rigrodsky Law, P.A. Announces Investigation of Mountain Crest Acquisition Corp. II Merger Globe NewsWire - Mon Apr 26, 2021

WILMINGTON, Del., April 26, 2021 (GLOBE NEWSWIRE) -- Rigrodsky Law, P.A. announces that it is investigating Mountain Crest Acquisition Corp. II (“Mountain Crest II”) (NASDAQ: MCAD ) regarding...

MCAD : 10.43 (-4.92%)
Better Therapeutics Commences Pivotal Study of Prescription Digital Therapeutic for the Treatment of Type 2 Diabetes Business Wire - Thu Apr 22, 2021

Better Therapeutics, Inc ., (“Better Therapeutics”) a prescription digital therapeutics company delivering cognitive behavioral therapy to address the root causes of cardiometabolic diseases, today...

MCAD : 10.43 (-4.92%)

Barchart Exclusives

Earnings, the Yen and Other Key Things to Watch This Week Barchart - 54 minutes ago
This week is relatively quiet on the news front, but there are still earnings due out and plenty of other macro factors to watch. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot